Considering the late observations that cancer cell pyroptosis (CCP), as a form of ICD, suppressed tumor growth by activating antitumor immunity (12–14), we asked whether the CCP-induced antitumor immunity by GSDMC might sensitize tumor cells to PARPi treatment. This evidence concerns the gene GSDMC and neoplasm.